---
title: "Vyne Therapeutics issues pre-funded warrants for 133,290 shares in stock exchange deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294409414.md"
description: "Vyne Therapeutics entered an exchange agreement to issue pre-funded warrants for 133,290 common shares in exchange for the same number of common shares. The warrants are immediately exercisable at $0.0001 per share, with exercise capped to avoid beneficial ownership exceeding 9.99%, adjustable to 19.99% upon notice. The transaction closed on July 29, 2026."
datetime: "2026-07-30T20:13:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294409414.md)
  - [en](https://longbridge.com/en/news/294409414.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294409414.md)
generator: "portal-rs"
---

# Vyne Therapeutics issues pre-funded warrants for 133,290 shares in stock exchange deal

-   Vyne Therapeutics entered an exchange agreement to issue pre-funded warrants for 133,290 common shares in exchange for 133,290 common shares. \* Pre-funded warrants are immediately exercisable at an exercise price of $0.0001 per share. \* Warrants cap exercise to avoid beneficial ownership above 9.99%, adjustable up to 19.99% with 61 days’ notice. \* Exchange closed July 29, 2026; 2,669,788 common shares outstanding, pre-funded warrants outstanding for 25,914,530 common shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyne Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-088662), on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [VYNE.US](https://longbridge.com/en/quote/VYNE.US.md)

## Related News & Research

- [Yarrow Bioscience files amended 8-K report on merger exchange ratio update](https://longbridge.com/en/news/295840217.md)
- [ReNew Energy Global warrants set to be delisted after expiration](https://longbridge.com/en/news/296360098.md)
- [Dogness issues 3,050,000 Class A shares after cash warrant exercise](https://longbridge.com/en/news/296088837.md)
- [ReconAfrica receives $4.97 million from warrant exercises](https://longbridge.com/en/news/296156008.md)
- [Cartesian Growth Corp IV units begin trading separately into shares and warrants Aug. 17](https://longbridge.com/en/news/295969617.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**